Aytu BioPharma (AYTU.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Aytu BioPharma released FY2026 Q1 earnings on November 13 After-Market EST, actual revenue USD 13.89 M (forecast USD 12.6 M), actual EPS USD -0.08 (forecast USD -0.255)

00:00

Nov6

Aytu BioPharma to release FY2026 Q1 earnings on November 13 After-Market EST, forecast revenue USD 12.6 M, EPS USD -0.255

00:08

Sep23

Aytu BioPharma released FY2025 Q4 earnings on September 23 After-Market EST, actual revenue USD 15.14 M (forecast USD 17.92 M), actual EPS USD -2.918 (forecast USD -0.05)

23:00

Aytu BioPharma released FY2025 earnings on September 23 After-Market EST, actual revenue USD 66.38 M (forecast USD 69.15 M), actual EPS USD -2.1596 (forecast USD 0.66)

23:00

Sep16

Aytu BioPharma to Release FY2025 Q4 Earnings on September 23 After-Market EST, Forecast Revenue USD 17.92 M, EPS USD -0.05

00:05

Jun23

Aytu BioPharma Expands Loan Agreement and Secures Public Offering

12:01